Velan Capital Investment Management LP
Position in DSGN — Design Therapeutics, Inc.
CIK 1848809
ALPHARETTA, GA
Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$212,800
+$25,200 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Velan Capital Investment Management LP holds $144,974,407 across 44 Biotechnology names. DSGN ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
100,781 | $32,470,630 | |
| 2 | TARA |
Protara Therapeutics, Inc.
|
2,834,652 | $14,768,536 | |
| 3 | STRO |
Sutro Biopharma, Inc.
|
512,160 | $12,757,905 | |
| 4 | EVMN |
Evommune, Inc.
|
446,255 | $10,259,402 | |
| 5 | MPLT |
MapLight Therapeutics, Inc.
|
492,893 | $10,020,514 | |
| 6 | TENX |
Tenax Therapeutics, Inc.
|
583,333 | $9,327,494 | |
| 7 | ABVX |
Abivax S.A.
|
77,000 | $8,573,950 | |
| 8 | HRTX |
Heron Therapeutics, Inc. /De/
|
8,753,290 | $7,002,632 |
All Filings in DSGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,800 | 20,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $187,600 | 20,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $150,600 | 20,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,400 | 20,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $54,040 | 14,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||